Risk of thromboembolic and bleeding outcomes following hematological cancers: A Danish population-based cohort study.
Kasper AdelborgPriscila CorrainiBianka DarvalicsHenrik FrederiksenAnne OrdingErzsébet Horváth-PuhóMikael RørthHenrik T SørensenPublished in: Journal of thrombosis and haemostasis : JTH (2019)
Approximately 2 of 10 hematological cancer patients experienced MI, ischemic stroke, VTE, or bleeding requiring hospital contact within 10 years. The hematological cancer cohort had higher hazards of MI, ischemic stroke, VTE, and bleeding requiring hospital contact than a general population comparison cohort.